Mosapride: Indication, Dosage, Side Effect, Precaution

Concise Prescribing Info Full Prescribing Info

Dosage/Direction for Use Special Precautions Adverse Reactions Drug Interactions Action CIMS Class ATC Classification

Concise Prescribing Info

Indications/Uses

Decreased GI motility.

Dosage/Direction for Use

Adult: PO As anhydrous citrate: 5 mg 3 times/day.

Special Precautions

Continuous admin of this drug is not recommended if no improvement in GI symptoms is observed after 2 wk of admin. Elderly, renal impairment, hepatic impairment.

Adverse Reactions

Diarrhoea, abdominal pain; dizziness; constipation; headache; insomnia; nausea.

Drug Interactions

Mosapride concentration increased by erythromycin. May increase risk of QT prolongation with QT prolonging drugs.

CIMS Class

GIT Regulators, Antiflatulents & Anti-Inflammatories

ATC Classification

A03FA09 - mosapride

Disclaimer: This information is independently developed by CIMS based on mosapride from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com